BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8134127)

  • 21. Soft tissue sarcoma metastasis from clonal expansion of p53 mutated tumor cells.
    Pollock RE; Lang A; Luo J; El-Naggar AK; Yu D
    Oncogene; 1996 May; 12(9):2035-9. PubMed ID: 8649865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal analysis of bilateral breast cancer.
    Shibata A; Tsai YC; Press MF; Henderson BE; Jones PA; Ross RK
    Clin Cancer Res; 1996 Apr; 2(4):743-8. PubMed ID: 9816225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The first documentation of Li-Fraumeni syndrome in Korea.
    Bang YJ; Kang SH; Kim TY; Jung CW; Oh SM; Choe KJ; Kim NK
    J Korean Med Sci; 1995 Jun; 10(3):205-10. PubMed ID: 8527048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of germline and tumor mutations of p53 gene in familial occurrence of soft tissue sarcomas.
    Kudawara I; Matsumine A; Ohzono K
    J Surg Oncol; 2007 Mar; 95(4):347-50. PubMed ID: 17192950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families.
    Manoukian S; Peissel B; Pensotti V; Barile M; Cortesi L; Stacchiotti S; Terenziani M; Barbera F; Pasquini G; Frigerio S; Pierotti MA; Radice P; Della-Torre G
    Eur J Cancer; 2007 Feb; 43(3):601-6. PubMed ID: 17224268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
    Gonzalez KD; Noltner KA; Buzin CH; Gu D; Wen-Fong CY; Nguyen VQ; Han JH; Lowstuter K; Longmate J; Sommer SS; Weitzel JN
    J Clin Oncol; 2009 Mar; 27(8):1250-6. PubMed ID: 19204208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Li-Fraumeni syndrome].
    Tokunaga A; Onda M; Matsukura N; Kato S
    Nihon Rinsho; 1995 Nov; 53(11):2797-802. PubMed ID: 8538047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation.
    Horio Y; Suzuki H; Ueda R; Koshikawa T; Sugiura T; Ariyoshi Y; Shimokata K; Takahashi T; Takahashi T
    Oncogene; 1994 Apr; 9(4):1231-5. PubMed ID: 8134126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detailed computational study of p53 and p16: using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants.
    Greenblatt MS; Beaudet JG; Gump JR; Godin KS; Trombley L; Koh J; Bond JP
    Oncogene; 2003 Feb; 22(8):1150-63. PubMed ID: 12606942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent p53 gene mutations and novel alleles in familial breast cancer.
    Glebov OK; McKenzie KE; White CA; Sukumar S
    Cancer Res; 1994 Jul; 54(14):3703-9. PubMed ID: 8033087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia.
    Felix CA; Nau MM; Takahashi T; Mitsudomi T; Chiba I; Poplack DG; Reaman GH; Cole DE; Letterio JJ; Whang-Peng J
    J Clin Invest; 1992 Feb; 89(2):640-7. PubMed ID: 1737852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas.
    Komuro H; Hayashi Y; Kawamura M; Hayashi K; Kaneko Y; Kamoshita S; Hanada R; Yamamoto K; Hongo T; Yamada M
    Cancer Res; 1993 Nov; 53(21):5284-8. PubMed ID: 8221663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. G:C > A:T mutations and potential epigenetic regulation of p53 in breast cancer.
    Kouidou S; Malousi A; Kyventidis A; Fragou A; Maglaveras N
    Breast Cancer Res Treat; 2007 Dec; 106(3):351-60. PubMed ID: 17505880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Balanced t(11;15)(q23;q15) in a TP53+/+ breast cancer patient from a Li-Fraumeni syndrome family.
    Sherif ZA; Danielsen M
    Cancer Genet Cytogenet; 2006 Jul; 168(1):50-8. PubMed ID: 16772121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.
    Nichols KE; Malkin D; Garber JE; Fraumeni JF; Li FP
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):83-7. PubMed ID: 11219776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel mutations in the MEN1 gene in subjects with multiple endocrine neoplasia-1.
    Jap TS; Chiu CY; Won JG; Wu YC; Chen HS
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):336-42. PubMed ID: 15730416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Li-Fraumeni syndrome].
    Frebourg T
    Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
    Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
    Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan.
    Chen FM; Hou MF; Wang JY; Chen TC; Chen DC; Huang SY; Chung YS; Lin SR
    Cancer Lett; 2004 Apr; 207(1):59-67. PubMed ID: 15050734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Li-Fraumeni syndrome in a Malaysian kindred.
    Ariffin H; Martel-Planche G; Daud SS; Ibrahim K; Hainaut P
    Cancer Genet Cytogenet; 2008 Oct; 186(1):49-53. PubMed ID: 18786442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.